Pliant Therapeutics, a Californian biopharma focused on discovering and developing fibrosis drugs, saw its shares close down ...

One such exporter is Beacon Pharmaceuticals, founded in 2006, which became the first company in Bangladesh to export cancer drugs. “It was founder Mohammad Ebadul Karim’s vision to transform ...

CANTON − Latrice Snodgrass, the new executive director of the Beacon Charitable Pharmacy, says one of her main goals is to make more people aware of the place she calls "a hidden gem." ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

On Monday, Kay & Que (Bangladesh), a publicly listed company, was also downgraded to the Z category for the same reason.

LONDON and CAMBRIDGE, Mass., Jan. 28, 2025 /PRNewswire/ -- Beacon Therapeutics Holdings Limited ('Beacon Therapeutics' or 'the Company'), a leading ophthalmic gene therapy company with a mission ...

Beacon Converters has joined Practice Greenhealth and become a sponsor of Practice Greenhealth’s Greening the OR® Initiative. Practice Greenhealth ...